From DCAT Week 2023: Supplier News: Packaging

A roundup of news from CDMOs/CMOs and suppliers in pharmaceutical packaging with news from PCI Pharma Services, Bormioli, and Tedor Pharma Services. Highlights below.  

* PCI Pharma Services Investing $50 M for New Packaging Facility for Injectables
* Bormioli Investing $55 M To Expand Pharma Packaging, Sustainability-Led Initiatives
* Tedor Pharma Services Adding Packaging, Serialization Line

PCI Pharma Services Investing $50 M for New Packaging Facility for Injectables 
PCI Pharma Services, a CDMO of drug products and a contract packager, is investing $50 million in a new 200,000-square-foot facility at its site in Rockford, Illinois, for specialized packaging for injectable drug-delivery-device combination products.  

With over 20 dedicated suites, the new facility will support the assembly and packaging of vials, pre-filled syringes, auto-injectors, and pen-cartridges. The facility will be validated in the summer of 2024 with capacity reservation available immediately. 

The investment is the latest in a series of manufacturing expansions by the company, including $100 million in a new large-scale sterile fill–finish facility in Bedford, New Hampshire, due to be operational in the fall of 2024, and robotic aseptic filling technologies already operational at the company’s facilities in San Diego, California, and Australia. 

Source: PCI Pharma Services 

Bormioli Investing $55 M To Expand Pharma Packaging, Sustainability-Led Initiatives 
Bormioli Pharma, a provider of pharmaceutical packaging, has launched its “50-in-5” program, which aims to achieve 50% sustainability in raw materials by 2025. The “50-in-5” program impacts the company’s entire manufacturing footprint by increasing use of recycled materials throughout production and adopting carbon-capture and green materials. To achieve this goal, Bormioli has been strengthening and expanding its industrial platform, with investments of EUR 50 million ($55 million) to date and plans for similar investments over the next three years to upgrade its high-value tubular glass vial capabilities and molded-glass platform while expanding cleanroom facilities for production of rubber and aluminum closures.  

Source: Bormioli Pharma 

Tedor Pharma Services Adding Packaging, Serialization Line 
Tedor Pharma Services, a CDMO of oral solid dosage forms, is expanding its current packaging capabilities and storage offerings with the addition of an automated cGMP solid-dose packaging and serialization line. The packaging and storage expansion plan includes the addition of a modular walk-in USP refrigeration warehouse for the storage and processing of clinical trial materials for secondary packaging and kitting.  Plus, the installation of an additional backup LP power generation system will allow the site to expand warehousing and stability services. The company plans to purchase, install, and qualify the new equipment within 2023.  

Source: Tedor Pharma Services